Noninvasive Detection of Response and Resistance in <i>EGFR</i> -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNAGeoffrey R. Oxnard, Pasi A. Jänne, Cloud P. Paweletz et al.|Clinical Cancer Research|2014Cited by 781
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b studyJeffrey S. Weber, Tal Zaks, Manju Morrissey et al.|The Lancet|2024Cited by 729
Imatinib for Melanomas Harboring Mutationally Activated or Amplified <i>KIT</i> Arising on Mucosal, Acral, and Chronically Sun-Damaged SkinF. Stephen Hodi, David E. Fisher, Christopher L. Corless et al.|Journal of Clinical Oncology|2013Cited by 594
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapyLucie Heinzerling, Jason J. Luke|Journal for ImmunoTherapy of Cancer|2016Cited by 510
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in MelanomaCatherine S. Grasso, Antoni Ribas, Jennifer Tsoi et al.|Cancer Cell|2020Cited by 379